Texas Attorney General Files Lawsuit Against Tylenol Manufacturers Concerning Autism Spectrum Allegations
The top legal official in Texas Paxton is taking legal action against the producers of Tylenol, alleging the corporations concealed safety concerns that the drug created to children's brain development.
The lawsuit follows four weeks after President Donald Trump promoted an unverified association between taking Tylenol - referred to as acetaminophen - during pregnancy and autism in children.
The attorney general is taking legal action against Johnson & Johnson, which once produced the medication, the sole analgesic suggested for pregnant women, and the current manufacturer, which now manufacturers it.
In a declaration, he said they "misled consumers by gaining financially from pain and pushing pills ignoring the risks."
The manufacturer states there is insufficient reliable data tying acetaminophen to autism.
"These corporations deceived for years, knowingly endangering numerous people to line their pockets," the attorney general, from the Republican party, declared.
The company stated officially that it was "deeply concerned by the dissemination of inaccurate information on the safety of acetaminophen and the potential impact that could have on the welfare of women and children in America."
On its website, Kenvue also said it had "consistently assessed the applicable studies and there is lacking reliable evidence that demonstrates a proven link between taking acetaminophen and autism."
Organizations representing physicians and healthcare providers concur.
The leading OB-GYN organization has said acetaminophen - the primary component in Tylenol - is one of the few options for pregnant women to manage pain and fever, which can pose significant medical dangers if not addressed.
"In multiple decades of research on the use of paracetamol in pregnancy, no reliable research has successfully concluded that the use of paracetamol in any period of gestation results in neurological conditions in offspring," the group commented.
The lawsuit cites current declarations from the previous government in arguing the medication is allegedly unsafe.
Last month, the former president generated worry from health experts when he told women during pregnancy to "resist strongly" not to take Tylenol when ill.
Federal regulators then issued a notice that medical professionals should think about restricting the use of Tylenol, while also declaring that "a direct connection" between the drug and autism spectrum disorder in minors has not been proven.
Health Secretary RFK Jr, who supervises the Food and Drug Administration, had vowed in April to initiate "extensive scientific investigation" that would establish the source of autism in a matter of months.
But authorities cautioned that discovering a single cause of autism - thought by researchers to be the outcome of a complex mix of genetic and surrounding conditions - would prove challenging.
Autism spectrum disorder is a type of permanent neurological difference and impairment that impacts how persons experience and relate to the environment, and is diagnosed using medical professional evaluations.
In his lawsuit, Paxton - who supports Trump who is campaigning for federal office - alleges the manufacturer and Johnson & Johnson "deliberately disregarded and attempted to silence the science" around paracetamol and autism spectrum disorder.
This legal action seeks to make the firms "remove any marketing or advertising" that states Tylenol is reliable for expectant mothers.
This legal action parallels the complaints of a collection of parents of minors with autism and attention deficit hyperactivity disorder who filed suit against the producers of Tylenol in recently.
Judicial authorities threw out the lawsuit, declaring studies from the parents' expert witnesses was not conclusive.